Hepatitis B Virus Elimination in the U.S.: Time to Dismantle Barriers and Implement Solutions

Purpose of Review The World Health Organization has set a target for the elimination of hepatitis B virus (HBV) infection as a public health threat by 2030, but the U.S. is not currently on track. In this review, we describe specific barriers to HBV elimination, provide examples of potential solutions, and offer recommendations for how the U.S. can reach HBV elimination goals. Recent Findings In the U.S., there are many barriers to eliminating hepatitis B, worsened by the siloing of healthcare and public health services. In recent years, we have not seen progress toward improving HBV screening or adult vaccination, and acute cases are on the rise. Current policies, guidelines, and recommendations can hinder elimination progress. Summary Simple policy and guideline changes will allow us to decentralize and scale-up hepatitis B screening, vaccination, and care. Dismantling current barriers will be critical to eliminating hepatitis B in the U.S.